Background. To further improve the screening, diagnosis, and therapy of patients with
nonsmall cell lung cancer (NSCLC) additional diagnostic tools are urgently needed. Gene …

Abstract Aim Cyclooxygenase‐2 (COX‐2) plays an important role in cell apoptosis,
angiogenesis and tumor invasion, and over‐expression of COX‐2 is associated with tumor …

Abstract The enzyme cyclooxygenase 2 (COX‑2) is known to be involved in tumorigenesis
and metastasis in certain types of cancer. Nevertheless, the prognostic value of COX‑2 …

Abstract Purpose: Cyclooxygenase-2 (COX-2) plays important roles in the modulation of
apoptosis, angiogenesis, immune response, and tumor invasion. Elevated COX-2 …

Objective To investigate cyclooxygenase-2 (COX-2) mRNA expression in curatively resected
non-small cell lung cancer (NSCLC) and to determine its association with prognosis …

Aim: To explore the association between COX-2 polymorphisms and non-small cell lung
cancer (NSCLC) susceptibility. Methods: We collected fasting peripheral venous blood from …

A new class of compounds targeting cyclooxygenase 2 (COX-2) together with other different
clinically used therapeutic strategies has recently shown a promise for the chemoprevention …

Background Cyclooxygenase-2 (COX-2) has been implicated in tumorigenesis and
metastasis, and it presumably mediates the proliferation of endothelial cells and promotes …

Context.—Previous studies report that increased expression of cyclooxygenase 2 (COX-2)
correlates with poor clinical outcome in several malignancies, including non–small cell lung …

BACKGROUND: Cyclooxygenase-2 (COX-2) is known to play a role in carcinogenesis and
tumor progression. The aim of this study was to evaluate the relationship between COX-2 …